Overview

Full Product Details

Author:   Terence Gourlay (University of Strathclyde, UK) ,  Serdar Gunaydin (Professor of Cardiovascular Surgery, University of Health Sciences, Ankara City Hospital Campus, Turkey)
Publisher:   Elsevier Science & Technology
Imprint:   Woodhead Publishing Ltd
Volume:   40
Dimensions:   Width: 15.60cm , Height: 1.60cm , Length: 23.40cm
Weight:   0.560kg
ISBN:  

9781845698003

ISBN 10:   1845698002
Pages:   272
Publication Date:   19 April 2012
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Awaiting stock  

Table of Contents

Contributor contact details Foreword Chapter 1: Historical development of minimised cardiopulmonary bypass Abstract: 1.1 Introduction and historical perspective 1.2 Cardiopulmonary bypass: from pioneering to refinement 1.3 Cardiopulmonary bypass: does size matter? 1.4 Conclusions Chapter 2: Anticoagulation protocols for minimized cardiopulmonary bypass Abstract: 2.1 Introduction: blood activation during cardiac surgery with cardiopulmonary bypass (CPB) 2.2 Anticoagulation during CPB: basic principles and historical notes 2.3 Heparin-bonded surfaces and other biocompatible treatments 2.4 Reduced systemic heparinization (RSH) 2.5 Contraindications 2.6 Future trends Chapter 3: Minimized extracorporeal circulation: physiology and pathophysiology Abstract: 3.1 Introduction: basic principles 3.2 The inflammatory cascade and biomarkers 3.3 Conclusions Chapter 4: Blood–surface interface in miniaturised extracorporeal circulation systems Abstract: 4.1 Introduction 4.2 Blood–surface contact in cardiopulmonary bypass (CPB) 4.3 Clinical benefits of miniaturised extracorporeal circulation systems Chapter 5: Hemodilution: physiology and pathophysiology Abstract: 5.1 Introduction 5.2 Basic physiology and pathophysiology of hemodilution 5.3 Microvascular alterations with hemodilution 5.4 Hemodilution and cardiopulmonary bypass (CPB) 5.5 Determinants of tissue oxygenation – functional capillary density (FCD) 5.6 Conclusions Chapter 6: Inflammatory response and minimized cardiopulmonary bypass Abstract: 6.1 Introduction 6.2 Cardiopulmonary bypass (CPB)-induced inflammatory cascade 6.3 Pharmacological antioxidants for CPB: impact on biochemical and clinical outcomes 6.4 Minimized CPB circuits 6.5 Acknowledgements 6.7 Appendix: abbreviations Chapter 7: Design and principles of the minimized extracorporeal circuit Abstract: 7.1 Introduction 7.2 Basic principles of minimized extracorporeal circulation 7.2 Evolution of minimized circuits 7.4 Minimized extracorporeal systems currently available 7.5 Surgical applications of minimized extracorporeal circulation 7.6 Controversies and challenges facing minimized cardiopulmonary bypass 7.7 Future trends in minimized cardiopulmonary bypass Chapter 8: Cardiopulmonary bypass perfusate Abstract: 8.1 Introduction 8.2 Crystalloid primes 8.3 Types of crystalloids and colloid agents used in prime 8.4 Pharmacological agents used in prime 8.5 Using prime in CPB procedures 8.6 Examples of prime combinations 8.7 Minimizing the use of prime 8.8 Conclusions Chapter 9: Myocardial preservation techniques for mini-bypass Abstract: 9.1 Introduction 9.2 Methods of myocardial protection 9.3 Myocardial protection in mini-bypass 9.4 Conclusion Chapter 10: Minimised cardiopulmonary bypass: objectives and indications Abstract: 10.1 Introduction: objectives of minimised cardiopulmonary bypass 10.2 Indications and patient selection 10.3 Future trends Chapter 11: Coronary artery bypass grafting (CABG) Abstract: 11.1 Introduction 11.2 History of coronary artery bypass grafting (CABG) 11.3 Patient selection (indications) for mini-invasive cardiopulmonary bypass 11.4 Conduits 11.5 Anastomoses techniques 11.6 Surgical management on mini-invasive cardiopulmonary bypass 11.7 Conclusions Chapter 12: Valve surgery using minimized perfusion circuits Abstract: 12.1 Introduction 12.2 Surgical and technical aspects 12.3 Blood management and patient treatment in valve surgery 12.4 Experience with closed-loop perfusion circuits in valve surgery Chapter 13: Minimising cardiopulmonary bypass in children Abstract: 13.1 Introduction 13.2 Challenges of cardiopulmonary bypass (CPB) in the congenital patient 13.3 Potential goals of mini-CPB 13.4 Mini-CPB and neurological outcome 13.5 Mini-CPB circuit design options in congenital heart surgery 13.6 Clinical trials 13.7 Alternative procedures to CPB 13.8 Conclusions 13.10 Appendix: abbreviations Chapter 14: Comparison of minimized circulation with off-pump coronary artery bypass (OPCAB) grafting and conventional surgery Abstract: 14.1 Introduction 14.2 Controversies and challenges facing off-pump coronary artery bypass (OPCAB) grafting 14.3 Studies comparing OPCAB with mini-cardiopulmonary bypass (mini-CPB) and mini-CPB assisted OPCAB 14.4 Future trends and competition between OPCAB and minimized cardiopulmonary bypass Chapter 15: Minimally invasive cardiac surgery, port-access and robotic surgery Abstract: 15.1 Introduction 15.2 Minimally invasive coronary artery bypass grafting 15.3 Minimally invasive valve surgery 15.4 Minimally invasive congenital surgery 15.5 Minimally invasive treatment of atrial fibrillation 15.6 Miscellaneous possibilities of minimally invasive surgery 15.7 Robotic surgery 15.8 Conclusions Index

Reviews

The book is comprehensive in its scope and authoritative in the experience of its chapter authors. I commend the book to all members of cardiac surgery teams - surgeons, cardiologists, anaesthetists and perfusionists., Professor Ken Taylor, Emeritus Professor of Cardiac Surgery, Imperial College and The Hammersmith Hospital, London (from the Foreword)

Author Information

Terence Gourlay is Professor of Medical Diagnostics in the Department of Biomedical Engineering at University of Strathclyde, UK. Dr Gunaydin currently serves as a faculty and clinical professor in the Department of Cardiovascular Surgery in Ankara City Hospital Campus, University of Health Sciences, Turkey. He studied histology and embryology and received PhD in Biomaterial Sciences in Tokyo Heart Institute, Japan. He is the Vice President for International Society of Minimally Invasive Extracorporeal Circulation (MiECTIS) and General Secretary of Turkish Enhanced recovery After Surgery (ERAS) Society. He also works as the scientific board member in Giganode Foundation and Heart Team Education Association. He directs international scientific projects on clinical evaluation and biomaterial confirmation of novel cardiopulmonary bypass-related technologies based on the prevention of inflammatory response, patient blood management and ERAS.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions